MS means "Meaningful and Special" at the Inn at Jackson.(multiple sclerosis)

From: Townsend Letter: The Examiner of Alternative Medicine | Date: May 1, 2006| Author: Mayne, Marti | Copyright information

The Inn at Jackson will open its doors with a special week of free lodging, workshops, and networking for people living with multiple sclerosis. From May 7 to May 11, 2006, the Inn at Jackson will be very selective about its guests, for this is the time set aside exclusively for persons or couples coping with multiple sclerosis (MS). This special week of workshops, rest, relaxation, and socialization is offered absolutely free of charge for people dealing with the rigors of MS. Any ...

Related newspaper, magazine, and journal articles from HighBeam Research

MS means "Meaningful and Special" at the Inn at Jackson.(multiple sclerosis)
Townsend Letter: The Examiner of Alternative Medicine ; The Inn at Jackson will open its doors with a special week of free lodging, workshops, and networking for people living with multiple sclerosis. From May 7 to May 11, 2006, the Inn at Jackson will be very selective about its guests, for this is the time set aside exclusively for persons or couples
Multiple sclerosis: clinical presentation, diagnosis and treatment.
American Family Physician ; Multiple sclerosis is the most common and most extensively studied demyelinating disease.[1] However, its etiology and pathogenesis are still not well understood. This article discusses the presumed pathogenesis of the disease, including genetic and environmental factors, offers suggestions on when
Epidemiology and current treatment of multiple sclerosis in Europe today
Journal of Rehabilitation Research and Development ; Abstract-Multiple sclerosis (MS) is a chronic disease affecting the central nervous system, usually leading to early disablement in young adults. At least 350,000 persons in Europe have the disease. Wide variations exist both between and within European countries in the incidence and prevalence of
Neuroimaging evaluation in multiple sclerosis.
American Family Physician ; Multiple sclerosis is the most common demyelinating disease. Although the cause remains unknown, current pathogenetic theory postulates an autoimmune phenomenon in response to an insult--possibly viral in nature--to the central nervous system. The lesions of multiple sclerosis are mimicked in
Childhood multiple sclerosis
Journal of Pediatric Neurology ; ... of MS is established, communicating such news to the parents is often both difficult ... as the manner in which neurological bad news is conveyed to parents can significantly ... Most families find the attitude of the news giver, combined with the clarity of the ...
Multiple sclerosis: Insights into molecular pathogenesis and therapy
Mayo Clinic Proceedings ; In 1989, a Symposium on Multiple Sclerosis was published in the Mayo Clinic Proceedings. Articles that encompassed pathology, immunology, epidemiology, clinical outcomes, therapeutics, and rehabilitation provided physicians who manage patients with multiple sclerosis as well as scientists with a
Rational clinical immunotherapy for multiple sclerosis
Mayo Clinic Proceedings ; ... Cladribine Group. Cladribine and chronic progressive multiple sclerosis: the results of a multicenter trial [abstract]. Late Breaking News (American Academy of Neurology); 1997; LBN9 81. Sipe JC, Romine JS, Koziol J, Zyroff J, McMillan R, Beutler E. Cladribine improves ...
New insights into the genetics of multiple sclerosis
Journal of Rehabilitation Research and Development ; ... the discovery of the role of APOE (apolipoprotein E) in late-onset Alzheimer's disease (14) and the availability of detailed maps of highly polymorphic markers (i.e., microsatellites) for all chromosomes, powered the rationale for the wide application of ...
Immunotherapy of multiple sclerosis--current practice and future directions
Journal of Rehabilitation Research and Development ; Abstract-Over the past decade, multiple sclerosis (MS) has become a treatable neurological disease. This paper reviews the therapies that have been studied to treat MS and discusses various treatment approaches on the horizon. Immunosuppressive and immunomodulatory therapies have been shown to
CHAPTER 1: Clinical and Epidemiologic Features of Multiple Sclerosis
Formulary ; EPIDEMIOLOGIC ASPECTS OF MULTIPLE SCLEROSIS Multiple sclerosis (MS) is a chronic, unpredictable disease of the central nervous system (CNS). Its effects can range from mild to severely disabling. In the worst cases, patients are rendered bedridden, dependent in all activities of daily living, and